Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Clinical trial NCT01458171 · COMPLETED

Trial details

NCT number: NCT01458171
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorder

Start date: 2011-04-01
Primary completion: 2012-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.